Are You Utilizing DAW Codes Correctly? Updated Tool Available!
In the September Newsline article, NCPDP Updates DAW Code Definitions to Encompass Interchangeable Biosimilars, you can find updated guidance for the utilization of Dispense As Written (DAW) codes with biologic drug products based on the August 2022 version of NCPDP Telecommunications Version D and Above Questions, Answers and Editorial Updates, set to go into effect October 15, 2023. Though the definitions were revised to include biologic drug products, the guidance holds true for all legend drugs. Now is the time to refamiliarize yourself with the best-practices for using DAW codes and to review DAW code audit pitfalls most seen by PAAS National® analysts. Additionally, the DAW Codes Explained tool has undergone a major overhaul to now include helpful tables, expanded DAW code definitions, PAAS tips, billing examples, and additional resources all in one place.
DAW Code Best Practices DAW Code Audit Pitfalls to Avoid PAAS Tips: If you are billing the brand name or reference drug product when equivalent products are available in the marketplace, think about why you are doing so, utilize the correct DAW code, and ensure appropriate documentation exists to support the code utilized.
- Potential HIPAA Violations Lead to $1.3 Million Settlement - November 23, 2023
- 3…2…1…The Countdown is On to Complete Annual Fraud, Waste & Abuse Training - November 5, 2023
- NEW PAAS Resource – Printable Signature Logbook - October 26, 2023